PantoPac
|
WikiDoc Resources for PantoPac |
|
Articles |
|---|
|
Most recent articles on PantoPac |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on PantoPac at Clinical Trials.gov Clinical Trials on PantoPac at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on PantoPac
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating PantoPac Risk calculators and risk factors for PantoPac
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for PantoPac |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
PantoPac is the brand name for a pharmaceutical treatment designed to eradicate helicobacter pylori in peptic ulcers. It is a fixed-dose combination of pantoprazole, claritromycin, and amoxicillin.